Details of the Drug

General Information of Drug (ID: DMR22NI)

• Drug Name: MOGUISTEINE
• Synonyms: BBR-2173; Moguisteine; Rac-2-[(2-Methoxyphenoxy)methyl]-beta-oxo-3-thiazolidinepropionic acid ethyl ester; Rac-3-[2-(Ethoxycarbonyl)acetyl]-2-(2-methoxyphenoxymethyl)thiazolidine

Indication

Disease Entry	ICD 11	Status	REF
Cough	MD12	Discontinued in Preregistration	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C16H21NO5S
  Canonical SMILES: CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC
  InChI: InChI=1S/C16H21NO5S/c1-3-21-16(19)10-14(18)17-8-9-23-15(17)11-22-13-7-5-4-6-12(13)20-2/h4-7,15H,3,8-11H2,1-2H3
  InChIKey: WSYVIAQNTFPTBI-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 65935
  CAS Number: 119637-67-1
  TTD ID: D0TR0Z
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003316)